NEKTAR THERAPEUTIC SYSTS (NASDAQ: NKTR)

View Portfolio
Back to Investopedia
Back to Investopedia




$11.71 0.31 (2.72%)
Real-time 12:00:00 AM ET
 Turn On
KEY STATS
52-Week High Price
12.28
52-Week Low Price
4.00
Avg Volume (3 Mo.)
1.00 M
Market Cap
1.06 B
P/E Ratio (TTM)
0.0
Diluted EPS (TTM)
-0.97
Shares
93.20 M
Dividend Rate ($) / (%)
0.00/0.00
80%
20%
You need to upgrade your Flash Player to view the graph.
View by Date Range:
12 Mo. Price Change : 143% - NKTR has outperformed the S&P 500 by 117%
SIMILAR COMPANIES
NameCurrent Price - Today's ChangeMarket Cap
CUBIST PHARMACEUTICALS (CBST) $20.58 -  $0.65(3.26%)1.17 B
ACORDA THERAPEUTICS INC (ACOR) $29.99 -  $0.07(0.23%)1.17 B
ISIS PHARMACEUTICALS INC (ISIS) $11.04 -  $0.04(0.36%)1.09 B
ALKERMES INC (ALKS) $11.43 -  $0.06(0.53%)1.06 B
WUXI PHARMATECH INC ADS (WX) $15.83 -  $0.09(0.57%)1.10 B
MANNKIND CORPORATION (MNKD) $9.20 -  $0.21(2.34%)0.99 B
SEATTLE GENETICS INC (SGEN) $9.59 -  $0.25(2.68%)0.94 B
PAR PHARMACEUTICAL COMP (PRX) $24.07 -  $1.32(5.20%)0.91 B
IMPAX LABORATORIES INC (IPXL) $13.66 -  $0.02(0.15%)0.84 B
SAVIENT PHARMACEUTICALS (SVNT) $12.81 -  $0.36(2.89%)0.83 B
As of February 09, 2010 at 6:35 PM ET
STOCK ANALYSIS
There are currently no Stock Analysis.
NKTR RELATED HEADLINES
arrow
Nektar Therapeutics (NasdaqNM: NKTR) NewsBite
Nektar Therapeutics (NasdaqNM: NKTR) opened at $9.86. So far today, the stock has hit a low of $9.15 and a high of $9.91. NKTR is now trading at $9.32, up $.86 (10.17%). Over the last 52 weeks the stock has ranged from a low of $2.45 to a high of $8.61. Shares of NKTR are on the move this morning after the company signed a licensing deal with AstraZeneca (AZN) to develop two of its experimental drug candidates. NKTR will receive an upfront payme...
At Market Intelligence Center 9/21/2009
arrow
Dell Shares Slip After Multibillion-Dollar Buy
This is a transcript of the Midday Update Business View video report.
Forbes.com 9/21/2009
arrow
Dell Deals But Street Sags
Computer maker's $3.9B acquisition of IT firm Perot can't boost broader market after losses overseas.
Forbes.com 9/21/2009
arrow
Nektar Therapeutics (NKTR) NewsBite - NKTR Hits 52-Week High
Nektar Therapeutics (NasdaqNM: NKTR) hit a new 52-Week high of $6.76 so far today. Currently the stock is up $0.57 (9.45%) to $6.60 on 1,126,528 shares traded. Today's high is up $4.15 from a 52-Week Low of $2.45. Nektar Therapeutics stock has been showing support around $5.58 and resistance in the $6.42 range. Technic...
At Market Intelligence Center 5/18/2009
arrow
Nektar completes $115M technology sale to Novartis

Forbes.com 12/31/2008
arrow
BRIEF-Nektar says closing of sale of assets to Novartis

Forbes.com 12/31/2008
View All Headlines
Stock Simulator- Free Account
Chart Advisor- Free Report
Sponsored Links
COLOSIM1